105 related articles for article (PubMed ID: 1682487)
1. Comparison of the behavioral and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist.
MacDonald E; Scheinin M; Scheinin H; Virtanen R
J Pharmacol Exp Ther; 1991 Nov; 259(2):848-54. PubMed ID: 1682487
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute administration of medetomidine on the behaviour, temperature and turnover rates of brain biogenic amines in rodents and reversal of these effects by atipamezole.
MacDonald E; Haapalinna A; Virtanen R; Lammintausta R
Acta Vet Scand Suppl; 1989; 85():77-81. PubMed ID: 2571282
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profiles of medetomidine and its antagonist, atipamezole.
Virtanen R
Acta Vet Scand Suppl; 1989; 85():29-37. PubMed ID: 2571275
[TBL] [Abstract][Full Text] [Related]
4. Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative.
MacDonald E; Scheinin H; Scheinin M
Eur J Pharmacol; 1988 Dec; 158(1-2):119-27. PubMed ID: 2906007
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenoceptor-mediated inhibition of gastric acid secretion by medetomidine is efficiently antagonized by atipamezole in rats.
Savola M; Savola JM; Puurunen J
Arch Int Pharmacodyn Ther; 1989; 301():267-76. PubMed ID: 2576195
[TBL] [Abstract][Full Text] [Related]
6. Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist.
Scheinin H; MacDonald E; Scheinin M
Eur J Pharmacol; 1988 Jun; 151(1):35-42. PubMed ID: 2901363
[TBL] [Abstract][Full Text] [Related]
7. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane.
Potter DE; Ogidigben MJ
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2799-805. PubMed ID: 1680113
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine.
Haapalinna A; Viitamaa T; MacDonald E; Savola JM; Tuomisto L; Virtanen R; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):570-82. PubMed ID: 9402036
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular actions of medetomidine and their reversal by atipamezole.
Savola JM
Acta Vet Scand Suppl; 1989; 85():39-47. PubMed ID: 2571276
[TBL] [Abstract][Full Text] [Related]
10. Protean agonism at alpha2A-adrenoceptors.
Jansson CC; Kukkonen JP; Näsman J; Huifang G; Wurster S; Virtanen R; Savola JM; Cockcroft V; Akerman KE
Mol Pharmacol; 1998 May; 53(5):963-8. PubMed ID: 9584224
[TBL] [Abstract][Full Text] [Related]
11. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests.
Pertovaara A; Kauppila T; Tukeva T
Eur J Pharmacol; 1990 Apr; 179(3):323-8. PubMed ID: 1973106
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
Doze V; Chen BX; Li Z; Maze M
Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
[TBL] [Abstract][Full Text] [Related]
13. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation.
Pertovaara A; Bravo R; Herdegen T
Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045
[TBL] [Abstract][Full Text] [Related]
14. Alpha 2-adrenergic receptor agonist effects on supraventricular and ventricular automaticity in dogs with complete atrioventricular block.
Day TK; Muir WW
Am J Vet Res; 1993 Jan; 54(1):136-41. PubMed ID: 8093993
[TBL] [Abstract][Full Text] [Related]
15. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
Honoré P; Chapman V; Buritova J; Besson JM
J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
[TBL] [Abstract][Full Text] [Related]
16. The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
Riekkinen P; Lammintausta R; Ekonsalo T; Sirviö J
Eur J Pharmacol; 1993 Jul; 238(2-3):263-72. PubMed ID: 8104809
[TBL] [Abstract][Full Text] [Related]
17. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
Chopin P; Colpaert FC; Marien M
J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
[TBL] [Abstract][Full Text] [Related]
18. Reduction of isoflurane anesthetic requirement by medetomidine and its restoration by atipamezole in dogs.
Ewing KK; Mohammed HO; Scarlett JM; Short CE
Am J Vet Res; 1993 Feb; 54(2):294-9. PubMed ID: 8094277
[TBL] [Abstract][Full Text] [Related]
19. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
Seidel WF; Maze M; Dement WC; Edgar DM
J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
[TBL] [Abstract][Full Text] [Related]
20. Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test.
Durcan MJ; Lister RG; Linnoila M
Neuropharmacology; 1989 Mar; 28(3):275-81. PubMed ID: 2566945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
